Fennec Announces Results of Annual Meeting
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On June 29, 2021, Fennec Pharmaceuticals announced the election of its management's proposed board nominees at the Annual General Meeting in Irvine, California. The results show strong shareholder support, with Dr. Khalid Islam receiving 99.05% approval and other nominees like Adrian Haigh and Chris A. Rallis also garnering over 97% support. Furthermore, 99.88% of shareholders approved the appointment of Haskell & White LLP as auditors, and 97.48% voted in favor of executive compensation. This indicates significant confidence from shareholders in the company's direction.
Positive
- Strong support for board nominees with votes exceeding 97% approval.
- 99.88% shareholder approval for auditor appointment.
- 97.48% approval for executive compensation.
Negative
- None.
Details
News Market Reaction – FENC
The recorded move for FENC in the trading session of this news was -3.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.
Detailed results of the vote for the election of directors are set out below:
| Name of Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld | ||
| Dr. Khalid Islam | 13,646,934 | 130,590 | ||||
| Mr. Adrian Haigh | 13,419,749 | 357,775 | ||||
| Mr. Chris A. Rallis | 13,611,818 | 165,706 | ||||
| Dr. Marco Brughera | 13,517,839 | 259,685 | ||||
| Dr. Jodi Cook | 13,519,400 | 258,124 | ||||
| Mr. Rostislav Raykov | 13,656,957 | 120,567 | ||||
Shareholders also voted
For further information, please contact:
Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.